These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 9083829)

  • 21. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
    Garg U; Zhang YV
    Methods Mol Biol; 2016; 1383():1-10. PubMed ID: 26660168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chiral drug analysis using mass spectrometric detection relevant to research and practice in clinical and forensic toxicology.
    Schwaninger AE; Meyer MR; Maurer HH
    J Chromatogr A; 2012 Dec; 1269():122-35. PubMed ID: 22858363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent applications of liquid chromatography-mass spectrometry in forensic science.
    Wood M; Laloup M; Samyn N; del Mar Ramirez Fernandez M; de Bruijn EA; Maes RA; De Boeck G
    J Chromatogr A; 2006 Oct; 1130(1):3-15. PubMed ID: 16716330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LC-MS (/MS) in clinical toxicology screening methods.
    Viette V; Hochstrasser D; Fathi M
    Chimia (Aarau); 2012; 66(5):339-42. PubMed ID: 22867548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MASS SPECTROMETRY ANALYSIS OF DRUGS OF ABUSE: CHALLENGES AND EMERGING STRATEGIES.
    Borden SA; Palaty J; Termopoli V; Famiglini G; Cappiello A; Gill CG; Palma P
    Mass Spectrom Rev; 2020 Sep; 39(5-6):703-744. PubMed ID: 32048319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing the linear dynamic range in LC-MS: is it valid to use a less abundant isotopologue?
    Trobbiani S; Stockham P; Scott T
    Drug Test Anal; 2017 Oct; 9(10):1630-1636. PubMed ID: 28207195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition.
    Broecker S; Herre S; Wüst B; Zweigenbaum J; Pragst F
    Anal Bioanal Chem; 2011 Apr; 400(1):101-17. PubMed ID: 21127842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control.
    Ojanperä I; Kolmonen M; Pelander A
    Anal Bioanal Chem; 2012 May; 403(5):1203-20. PubMed ID: 22302167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantification in blood and oral fluid.
    Maurer HH
    Anal Bioanal Chem; 2005 Jan; 381(1):110-8. PubMed ID: 15309372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of an improved general unknown screening procedure using liquid chromatography-electrospray-mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography--diode array detection.
    Saint-Marcoux F; Lachâtre G; Marquet P
    J Am Soc Mass Spectrom; 2003 Jan; 14(1):14-22. PubMed ID: 12504330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology?
    Marquet P
    Ther Drug Monit; 2002 Feb; 24(1):125-33. PubMed ID: 11805733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and analytical toxicology of opiate, cocaine and amphetamine].
    Feliu C; Fouley A; Millart H; Gozalo C; Marty H; Djerada Z
    Ann Biol Clin (Paris); 2015; 73(1):54-69. PubMed ID: 25582723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-Resolution Mass Spectrometry for Untargeted Drug Screening.
    Wu AH; Colby J
    Methods Mol Biol; 2016; 1383():153-66. PubMed ID: 26660184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomedical and biochemical applications of liquid chromatography-mass spectrometry.
    Gelpí E
    J Chromatogr A; 1995 May; 703(1-2):59-80. PubMed ID: 7599744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - Where do we stand today?
    Meyer MR; Maurer HH
    Anal Chim Acta; 2016 Jul; 927():13-20. PubMed ID: 27237833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent studies on the electrospray ionisation mass spectrometric behaviour of selected nitrogen-containing drug molecules and its application to drug analysis using liquid chromatography-electrospray ionisation mass spectrometry.
    Smyth WF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):1-20. PubMed ID: 16095984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LC/MS with a particle beam interface in forensic toxicology.
    Spratt E; Vallaro GM
    Clin Lab Med; 1998 Dec; 18(4):651-63, viii. PubMed ID: 9891604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How can analytical diagnostics in clinical toxicology be successfully performed today?
    Maurer HH
    Ther Drug Monit; 2012 Oct; 34(5):561-4. PubMed ID: 22972537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent trends in analytical procedures in forensic toxicology.
    Van Bocxlaer JF
    Ther Drug Monit; 2005 Dec; 27(6):752-5. PubMed ID: 16404816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.